News | June 03, 2026
Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations
The company is building a connected healthcare ecosystem that utilises smart healthcare kiosk and mobile app to deliver at-home, AI-assisted health screenings and non-invasive health measurements
Crucially, Lupin is the exclusive first-to-file applicant for this product and is eligible for 180-day generic drug exclusivity in the U.S. market
The approved product is the generic equivalent of Sutab® Tablets developed by Azurity Pharmaceuticals
The ruling comes against the backdrop of a mounting trauma burden in India, where nearly 4.67 lakh accidental deaths occur annually
First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
Subscribe To Our Newsletter & Stay Updated
